Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleAN ACTIVE ANTI-AB40 VACCINE (ABVAC40) PROVED TO BE SAFE AND IMMUNOGENIC IN THE PHASE I CLINICAL TRIAL.AuthorsLacosta, Ana M.; Pérez-Grijalba, Virginia; Marcos, Ivan; Sarasa, Leticia; San José, Itziar; Núñez, Laura; Boada, Mercè; Tárraga, Lluis; Ruiz, Agustin; Pesini, Pedro; Sarasa, ManuelPublicationAlzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, Vol 12, pP199ISSN1552-5260Publication typeArticleDOI10.1016/j.jalz.2016.06.348